Whittier Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55
Closed -$1.73K 1348
2025
Q4
$1.73K Hold
55
﹤0.01% 1293
2025
Q3
$1.65K Hold
55
﹤0.01% 1306
2025
Q2
$1.34K Hold
55
﹤0.01% 1436
2025
Q1
$1.14K Hold
55
﹤0.01% 1428
2024
Q4
$1.29K Buy
+55
New +$1.35K ﹤0.01% 1483
2022
Q2
Sell
-700
Closed -$32K 1673
2022
Q1
$32K Buy
+700
New +$33.4K ﹤0.01% 1078

Other funds holding ARKG

Whittier Trust's ARKG Position: Q1 2026 in Review

Whittier Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 55 shares — an estimated $1.73K sold.

Whittier Trust first reported a position in ARKG in Q1 2022 and held it in 6 quarters. The position peaked at $32K in Q1 2022. 219 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Whittier Trust reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Whittier Trust sold 55 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $1.73K.
  • Whittier Trust first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 6 quarters.
  • Whittier Trust's ARK Genomic Revolution ETF position peaked at $32K in Q1 2022.
  • 219 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.